Actinogen Medical Limited

A$0.04As of Sun 8 Nov 2026, 12:00 UTC
ASX:ACWHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR 1.51%
Div yield —
ROE (77.46%)
Biotechnology
Beta (5Y) 0.80
PE TTM —
TSR TTM 17.14%
Mkt cap A$157.8M
ROIC (40.41%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0491
19.83%
(61.00%)
Hold 2|5|7|6|10
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
10.36%
18.69%
12.75%
20.61%
Revenue$M
7.349
7.682
7.626
7.763
5.91%
11.97%
5.10%
6.85%
Peers (US$108.4M)
Cap (US$)
PE
107.6M
—
Capital
TTM
5Y
10Y
Leveragex
0.809
(0.206)
(0.167)
EBIT/Intx
0.731
2.330
2.275
Own earn%
(626.31)
49.48
49.70
Sh yield%
40.83
43.80
43.13
Owners
Insiders/Inst%
2.46
64.78
Short interest%
3.67
SBC / revenue%
1.44
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
15–22
$1 testx
—
Incr. ROIC%
0